{"id":224409,"date":"2025-06-30T00:00:00","date_gmt":"2025-06-30T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041119-medtech-interventional-cardiology-devices-market\/"},"modified":"2026-03-31T10:09:40","modified_gmt":"2026-03-31T10:09:40","slug":"47042541-medtech-interventional-cardiology-devices-market-insights-latin-america","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47042541-medtech-interventional-cardiology-devices-market-insights-latin-america\/","title":{"rendered":"Interventional Cardiology Devices – Market Insights – Latin America"},"content":{"rendered":"

The Latin American IC<\/abbr> device market will see strong growth over the forecast period, driven by a rising patient population, the introduction of next-generation devices, and the expanding adoption of complex PCI<\/abbr>s. Furthermore, premium-priced advanced technologies\u2014such as lithotripsy balloons,\u00a0DCB<\/abbr>s, and newer-generation stents\u2014are witnessing strong uptake. These innovations are expected to reshape current treatment algorithms, thereby disrupting the dominance of established category leaders.<\/p>\n

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for IC<\/abbr> devices in the Latin American region from 2019 through 2034.<\/p>\n

The increasing prevalence of complex PCI<\/abbr> cases will drive demand for innovative devices and result in a higher proportion of complex PCI<\/abbr>s.<\/strong><\/p>\n

Which factors are contributing to the increasing prevalence of complex CAD<\/abbr> cases?<\/p>\n

What factors are influencing complex PCI<\/abbr> procedure volume growth in the Latin American IC<\/abbr> device market?<\/p>\n

Despite the increasing prevalence of complex PCI<\/abbr>s, what factors are limiting the uptake of innovative devices in the Latin American IC<\/abbr> device market?<\/p>\n

There is a growing competition in the Latin American IC<\/abbr> device market.<\/strong><\/p>\n

What are the future prospects of the companies operating in the market?<\/p>\n

Which companies are expected to launch their products in the Latin American IC<\/abbr> device market?<\/p>\n

Which new competitors are expected to enter this market?<\/p>\n

Positive clinical data supporting the use of DCB<\/abbr>s and specialty balloons is expected to influence physician practice over the forecast period.<\/b><\/p>\n

How strongly is favorable clinical data expected to impact the\u00a0DCB<\/abbr>\u00a0and specialty balloon markets?<\/p>\n

How has clinical data impacted major market players in these segments?<\/p>\n

What new products and competitors are expected to change market dynamics in these segments?<\/p>\n

What is the expected impact of emerging balloon-based technologies such as DCB<\/abbr>s?<\/p>\n

Device ASP<\/abbr> trends will play a significant role in determining market growth through 2034.<\/strong><\/p>\n

How will government-driven pricing pressures and increasing competition affect ASP<\/abbr>s?<\/p>\n

Which product segments will be the most impacted?<\/p>\n

Adoption of some premium-priced products, such as lithotripsy balloons, DCB<\/abbr>s, and BRS<\/abbr>, will be limited through 2034.<\/strong><\/p>\n

How has the commercialization of the lithotripsy balloons, DCB<\/abbr>s, and BRS<\/abbr> impacting other competing products?<\/p>\n

How are these technologies likely to evolve over the coming years?<\/p>\n

New technologies are expected to receive approval in the near future and change the way complex PCI<\/abbr>s are diagnosed and treated.<\/strong><\/p>\n

What is the impact of the latest generation of alternative coronary physiology modalities such as resting index or imaging-based FFR<\/abbr>angio<\/sub> and FFR<\/abbr>CT<\/abbr><\/sub> on the patient and procedure in cardiac catheterization labs?<\/p>\n

How are novel technologies with improved outcomes performing against the already approved products in the covered markets?<\/p>\n

What are the recent events in the advanced diagnostic imaging space? How will these impact the existing players going forward?<\/p>\n

How CCTA<\/abbr> is expected to impact diagnostic angiography in the coming years?<\/p>\n

How are IVUS<\/abbr> and OCT<\/abbr> competing against the conventional diagnostic angiography techniques? How are clinical trials impacting the use of these products?<\/p>\n

How will the emergence of alternative FFR<\/abbr> modalities affect the FFR<\/abbr> pressure guidewire market?<\/p>\n","protected":false},"template":"","class_list":["post-224409","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-interventional-cardiology-devices","medtech-geography-latin-america","medtech-date-2294"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224409","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":4,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224409\/revisions"}],"predecessor-version":[{"id":486789,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/224409\/revisions\/486789"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=224409"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}